Lescol for children

Lescol (fluvastatin) capsules and Lescol XL (fluvastatin) prolonged release tablets are now licensed for the treatment of heterozygous familial hypercholesterolaemia in children over nine years.

The Lescol (fluvastatin) range was previously contraindicated in children under 18 years.

The recommended starting dose is 40mg or 80mg daily; 20mg may be adequate in mild cases.

The safety and efficacy of Lescol and Lescol XL has not been studied for treatment periods longer than two years. The summary of product characteristics also warns that the potential risks and benefits of treatment should be carefully evaluated in pre-pubertal children as experience is limited in this group.

View Lescol drug record

Further information: Novartis

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

PHE issues coronavirus guidance for primary care

PHE issues coronavirus guidance for primary care

Public Health England (PHE) has issued guidance for...

HPV infections fall dramatically but researchers say vaccine efficacy is 'uncertain'

HPV infections fall dramatically but researchers say vaccine efficacy is 'uncertain'

Cancer-causing HPV16 and 18 infections are now 'extremely...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: Adcal D3 Dissolve, Diamox SR, flumetasone/clioquinol,...